\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ focal\\ neurologic\\ deficits\\.\ \(1\)\
\-\ this\\ patient\\ had\\ an\\ incidental\\ mass\\ found\\ on\\ a\\ head\\ ct\\ after\\ a\\ fall\\.\\ \\ he\\ has\\ no\\ history\\ of\\ seizures\\ or\\ focal\\ neurologic\\ deficits\\.\\ \\ the\\ patient\\ elected\\ to\\ have\\ a\\ gross\\ total\\ resection\\ of\\ the\\ mass\\.\\ \\ he\\ continues\\ to\\ be\\ free\\ of\\ seizures\\ and\\ focal\\ neurologic\\ deficits\\ at\\ one\\ month\\ post\\-op\\.\ \(0\)\
\-\ right\\ frontal\\ lobe\\ lesion\\ without\\ midline\\ shift\\ or\\ sulcal\\ effacement\\,\\ measuring\\ 3\\.5\\ x\\ 2\\.9\\ x\\ 3\\.0\\ cm\\.\\ \\ on\\ ct\\,\\ the\\ lesion\\ low\\ attenuation\\ compared\\ \\ to\\ brain\\.\\ \\ on\\ mri\\,\\ it\\ has\\ corresponding\\ low\\ signal\\ on\\ t1\\ and\\ high\\ on\\ t2\\.\\ \\ there\\ is\\ no\\ post\\-contrast\\ enhancement\\ and\\ demonstrates\\ no\\ suppression\\ on\\ flair\\.\ \(0\)\
\-\ diffuse\\ astrocytoma\\ who\\ gr\\ 2\ \(0\)\
\-\ \\â\\€\\¢\\ diffuse\\ astrocytoma\\ \\(gr\\ 2\\ or\\ gr\\ 3\\)\ \(0\)\
\-\ \\â\\€\\¢\\ pleomorphic\\ xanthoastrocytoma\\ \\(pxa\\)\ \(0\)\
\-\ \\â\\€\\¢\\ pilocytic\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ anaplastic\\ astrocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ dnet\\ \\(dysembryoplastic\\ neuroepithelial\\ tumor\\)\ \(0\)\
\-\ \\â\\€\\¢\\ neurocysticercosis\ \(0\)\
\-\ \\â\\€\\¢\\ metastasis\ \(6\)\
\-\ this\\ patient\\ is\\ a\\ 35\\ year\\ old\\ man\\ who\\ presents\\ after\\ a\\ fall\\.\\ \\ he\\ has\\ no\\ history\\ of\\ seizures\\ or\\ focal\\ neurologic\\ deficits\\.\ \(0\)\
\-\ diffuse\\ astrocytomas\\ are\\ grade\\ 2\\ astrocytic\\ tumors\\ according\\ to\\ the\\ who\\ classification\\ of\\ cns\\ masses\\ \\(1\\)\\.\\ \\ they\\ often\\ present\\ in\\ the\\ 4th\\-5th\\ decade\\ of\\ life\\ \\(2\\)\\,\\ with\\ most\\ being\\ found\\ in\\ the\\ frontal\\ lobe\\ \\(40\\%\\)\\ \\(3\\)\\.\\ \\ patients\\ typically\\ present\\ late\\ and\\ have\\ a\\ history\\ of\\ seizures\\.\\ \\ on\\ mri\\,\\ these\\ lesions\\ are\\ typically\\ bright\\ on\\ t2\\,\\ but\\ do\\ not\\ enhance\\ and\\ do\\ not\\ suppress\\ on\\ flair\\.\\ \\ occasionally\\,\\ high\\ t2\\ intensity\\ can\\ be\\ see\\ surrounding\\ the\\ lesion\\.\\ \\ this\\ represents\\ infiltration\\ of\\ the\\ astrocytoma\\,\\ but\\ it\\ can\\ be\\ mistaken\\ for\\ edema\\.\ \(0\)\
\-\ these\\ neoplasms\\ have\\ a\\ variable\\ course\\,\\ with\\ some\\ progressing\\ malignantly\\ to\\ higher\\ grade\\ gliomas\\ \\(anaplastic\\ or\\ gbms\\)\\.\\ \\ indicators\\ that\\ confer\\ better\\ prognostic\\ include\\:\\ higher\\ degree\\ of\\ function\\ on\\ the\\ kps\\ scale\\ \\(\\>80\\)\\,\\ location\\ of\\ the\\ lesion\\ in\\ non\\-eloquent\\ locations\\,\\ size\\ of\\ the\\ lesion\\ less\\ than\\ 4cm\\,\\ and\\ age\\ less\\ than\\ 50\\ \\(2\\)\\.\\ \\ similar\\ patients\\ with\\ all\\ of\\ these\\ indicators\\ have\\ a\\ pre\\-op\\ 10\\ year\\ survival\\ of\\ 90\\%\\ \\(2\\)\\.\ \(0\)\
\-\ resection\\ of\\ these\\ lesions\\ is\\ controversial\\.\\ \\ pathologically\\,\\ these\\ lesions\\ are\\ often\\ infiltrative\\.\\ \\ \\ if\\ gross\\ total\\ resection\\ is\\ chosen\\ by\\ the\\ neurosurgeon\\ and\\ the\\ patient\\,\\ \\>50\\%\\ will\\ recur\\ in\\ 5\\ years\\ \\(4\\)\\.\ \(0\)\
\-\ mr\\ spectroscopy\ \(0\)\
\-\ in\\ some\\ cases\\,\\ it\\ may\\ be\\ difficult\\ to\\ determine\\ whether\\ or\\ not\\ an\\ abnormality\\ on\\ mri\\ represents\\ a\\ benign\\ or\\ malignant\\ lesion\\.\\ \\ proton\\ mr\\ spectroscopy\\ \\(mrs\\ or\\ 1hmrs\\)\\ can\\ be\\ a\\ useful\\ \\ adjunct\\ to\\ mri\\.\\ \\ mrs\\ uses\\ the\\ same\\ nuclear\\ magnetic\\ resonance\\ mechanisms\\ used\\ in\\ mri\\,\\ but\\ instead\\ of\\ creating\\ an\\ image\\,\\ it\\ creates\\ a\\ spectrum\\ representing\\ the\\ biochemical\\ composition\\ a\\ region\\ of\\ interest\\.\\ \\ lesions\\ have\\ unique\\ biochemical\\ signatures\\ that\\ can\\ assist\\ in\\ diagnosis\\.\ \(0\)\
\-\ normal\\ brain\\ tissue\\ has\\ major\\ peaks\\ for\\ the\\ molecules\\ myo\\-inositol\\,\\ choline\\,\\ creatinine\\,\\ and\\ n\\-acetylaspartate\\.\\ \\ on\\ the\\ spectra\\,\\ these\\ are\\ read\\ left\\ to\\ right\\,\\ and\\ generally\\ will\\ have\\ a\\ upward\\ angle\\ of\\ 45\\ degrees\\ \\(5\\)\\.\\ \\ this\\ angle\\ is\\ known\\ as\\ the\\ hunter\\â\\€\\™s\\ angle\\ \\(5\\)\\.\\ \\ the\\ angle\\ is\\ deranged\\ when\\ any\\ of\\ these\\ compounds\\ are\\ greater\\ or\\ less\\ than\\ normal\\,\\ and\\ this\\ can\\ indicate\\ pathology\\.\\ \\ \ \(0\)\
\-\ examining\\ these\\ peaks\\ closer\\,\\ choline\\ on\\ mrs\\ represents\\ cellular\\ turn\\ over\\,\\ while\\ n\\-acetylaspartate\\ represents\\ normal\\ neural\\ tissue\\ \\(5\\)\\.\\ \\ an\\ increase\\ of\\ choline\\ and\\ a\\ decrease\\ of\\ n\\-acetylaspartate\\ can\\ represent\\ neoplasia\\ \\(5\\)\\.\\ \\ elevated\\ lactate\\ can\\ be\\ seen\\ on\\ the\\ spectrum\\,\\ which\\ is\\ also\\ a\\ useful\\ indicator\\ for\\ neoplasia\\ \\(5\\)\\.\ \(0\)\
\-\ mrs\\ takes\\ experience\\ to\\ understand\\ and\\ interpret\\ correctly\\.\\ \\ certain\\ other\\ molecules\\ in\\ the\\ system\\ and\\ physiologic\\ states\\ can\\ make\\ mrs\\ more\\ complex\\.\\ \\ for\\ instance\\,\\ \\ the\\ neonatal\\ brain\\ can\\ look\\ similar\\ to\\ neoplasia\\ due\\ to\\ increased\\ cellular\\ turnover\\.\\ \\ additionally\\,\\ alcohol\\,\\ mannitol\\,\\ glucose\\,\\ and\\ many\\ common\\ medications\\ can\\ be\\ present\\ in\\ the\\ patient\\ and\\ the\\ region\\ of\\ interest\\,\\ changing\\ the\\ appearance\\ of\\ the\\ spectrum\\ with\\ their\\ unique\\ chemical\\ shifts\\ \\(5\\)\\.\\ \\ \ \(0\)\
\-\ unfortunately\\,\\ despite\\ 20\\ years\\ of\\ existence\\,\\ there\\ is\\ scant\\ research\\ in\\ this\\ aspect\\ of\\ mri\\,\\ despite\\ it\\ being\\ a\\ noninvasive\\ and\\ relatively\\ inexpensive\\ adjunct\\ to\\ mr\\ imaging\\ that\\ physicians\\ already\\ request\\ \\(5\\)\\.\\ \\ at\\ the\\ same\\ time\\,\\ small\\,\\ but\\ growing\\ utility\\ has\\ been\\ found\\ in\\ the\\ diagnosis\\ and\\ treatment\\ of\\ a\\ variety\\ of\\ pathologic\\ conditions\\ of\\ the\\ brain\\.\\ \\ some\\ research\\ has\\ also\\ been\\ conducted\\ in\\ various\\ other\\ tissues\\,\\ including\\ the\\ kidney\\,\\ liver\\,\\ and\\ breast\\,\\ but\\ more\\ research\\ is\\ into\\ this\\ technology\\ is\\ needed\\ to\\ improve\\ clinical\\ applicability\\.\ \(0\)\
\-\ \\-\\-\ \(461\)\
\-\ 1\\.\\ \\ louis\\ dn\\,\\ ohgaki\\ h\\,\\ et\\ al\\.\\ the\\ 2007\\ who\\ classification\\ of\\ tumours\\ of\\ the\\ central\\ nervous\\ system\\.\\ acta\\ neuropathol\\ 114\\(2\\)\\:\\ 97\\-109\\.\ \(0\)\
\-\ 2\\.\\ \\ chang\\ ef\\,\\ smith\\ js\\,\\ et\\ al\\.\\ preoperative\\ prognostic\\ classification\\ system\\ for\\ hemispheric\\ low\\-grade\\ gliomas\\ in\\ adults\\.\\ j\\ neurosurg\\ 109\\(5\\)\\:\\ 817\\-24\\.\ \(0\)\
\-\ 3\\.\\ \\ larjavaara\\ sr\\,\\ mantyla\\,\\ et\\ al\\.\\ \\ incidence\\ of\\ gliomas\\ by\\ anatomic\\ location\\.\\ neuro\\ oncol\\ 9\\(3\\)\\:\\ 319\\-25\\.\ \(0\)\
\-\ 4\\.\\ \\ shaw\\ eg\\,\\ berkey\\ b\\,\\ et\\ al\\.\\ recurrence\\ following\\ neurosurgeon\\-determined\\ gross\\-total\\ resection\\ of\\ adult\\ supratentorial\\ low\\-grade\\ glioma\\:\\ results\\ of\\ a\\ prospective\\ clinical\\ trial\\.\\ j\\ neurosurg\\ 109\\(5\\)\\:\\ 835\\-41\\.\ \(0\)\
\-\ 5\\.\\ \\ lin\\ a\\,\\ ross\\ bd\\,\\ et\\ al\\.\\ efficacy\\ of\\ proton\\ magnetic\\ resonance\\ spectroscopy\\ in\\ neurological\\ diagnosis\\ and\\ neurotherapeutic\\ decision\\ making\\.\\ neurorx\\ 2\\(2\\)\\:\\ 197\\-214\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mrs\\:\\ 0\\.04165318586362335\ \(0\)\
\-\ 5\\:\\ 0\\.025642670999427318\ \(0\)\
\-\ n\\-acetylaspartate\\:\\ 0\\.02499191151817401\ \(0\)\
\-\ choline\\:\\ 0\\.021137256230495952\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.020039794864530624\ \(0\)\
\-\ can\\:\\ 0\\.01987920361506738\ \(0\)\
\-\ gr\\:\\ 0\\.01859362985146682\ \(0\)\
\-\ al\\:\\ 0\\.018577238836288656\ \(0\)\
\-\ \\(\\:\\ 0\\.018522095544714373\ \(0\)\
\-\ \\)\\:\\ 0\\.018295838259315515\ \(0\)\
\-\ these\\:\\ 0\\.01824693080580792\ \(0\)\
\-\ neoplasia\\:\\ 0\\.018231220510985642\ \(0\)\
\-\ et\\:\\ 0\\.01793537656472965\ \(0\)\
\-\ research\\:\\ 0\\.01775691072690177\ \(0\)\
\-\ gliomas\\:\\ 0\\.017346044903441698\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.017017180506016902\ \(0\)\
\-\ 2\\:\\ 0\\.016985579967789658\ \(0\)\
\-\ represents\\:\\ 0\\.016845079887811955\ \(0\)\
\-\ angle\\:\\ 0\\.016457425145572274\ \(0\)\
\-\ deficits\\:\\ 0\\.016042025212422845\ \(0\)\
\-\ molecules\\:\\ 0\\.015239433975069964\ \(0\)\
\-\ spectrum\\:\\ 0\\.01521328434787264\ \(0\)\
\-\ seizures\\:\\ 0\\.01507222509728754\ \(0\)\
\-\ classification\\:\\ 0\\.015026747049975914\ \(0\)\
\-\ indicators\\:\\ 0\\.014781703613399791\ \(0\)\
\-\ 109\\:\\ 0\\.014781703613399791\ \(0\)\
\-\ neurologic\\:\\ 0\\.014639976827922101\ \(0\)\
\-\ \\,\\:\\ 0\\.014160218811673493\ \(0\)\
\-\ biochemical\\:\\ 0\\.014091504153663968\ \(0\)\
\-\ peaks\\:\\ 0\\.013575987377703136\ \(0\)\
\-\ adjunct\\:\\ 0\\.012821680136420432\ \(0\)\
\-\ interest\\:\\ 0\\.012821680136420432\ \(0\)\
\-\ neurosurg\\:\\ 0\\.012821680136420432\ \(0\)\
\-\ mri\\:\\ 0\\.012081697568705353\ \(0\)\
\-\ prognostic\\:\\ 0\\.011742514811503964\ \(0\)\
\-\ cellular\\:\\ 0\\.011742514811503964\ \(0\)\
\-\ have\\:\\ 0\\.011387311251477487\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.011250359447355092\ \(0\)\
\-\ proton\\:\\ 0\\.01124782341290522\ \(0\)\
\-\ unique\\:\\ 0\\.011175841218420562\ \(0\)\
\-\ anaplastic\\:\\ 0\\.011039038398936107\ \(0\)\
\-\ resection\\:\\ 0\\.010932987304698332\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.010732306636944387\ \(0\)\
\-\ lesion\\:\\ 0\\.01071110908307972\ \(0\)\
\-\ brain\\:\\ 0\\.010549134454575433\ \(0\)\
\-\ on\\:\\ 0\\.010394332485247173\ \(0\)\
\-\ system\\:\\ 0\\.010352246062771686\ \(0\)\
\-\ resonance\\:\\ 0\\.010274576275274212\ \(0\)\
\-\ magnetic\\:\\ 0\\.01005845214059149\ \(0\)\
\-\ focal\\:\\ 0\\.010012281452875495\ \(0\)\
\-\ has\\:\\ 0\\.00987507674150325\ \(0\)\
\-\ it\\:\\ 0\\.009850504536066751\ \(0\)\
\-\ be\\:\\ 0\\.009460817500930772\ \(0\)\
\-\ lesions\\:\\ 0\\.009384863615770041\ \(0\)\
\-\ but\\:\\ 0\\.009346170774530963\ \(0\)\
\-\ or\\:\\ 0\\.00924482537504961\ \(0\)\
\-\ useful\\:\\ 0\\.00914627609697827\ \(0\)\
\-\ who\\:\\ 0\\.009140383216991598\ \(0\)\
\-\ 4th\\-5th\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ malignantly\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ kps\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ non\\-eloquent\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ 1hmrs\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ signatures\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ myo\\-inositol\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ spectra\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ deranged\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ applicability\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ neuropathol\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ 97\\-109\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ 817\\-24\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ larjavaara\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ mantyla\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ 319\\-25\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ shaw\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ berkey\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ neurosurgeon\\-determined\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ gross\\-total\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ 835\\-41\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ neurotherapeutic\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ 197\\-214\\:\\ 0\\.009041557357914357\ \(0\)\
\-\ less\\:\\ 0\\.008904430782531331\ \(0\)\
\-\ higher\\:\\ 0\\.008595990996271235\ \(0\)\
\-\ mr\\:\\ 0\\.008354459913681335\ \(0\)\
\-\ gross\\:\\ 0\\.008349920606365637\ \(0\)\
\-\ ohgaki\\:\\ 0\\.00833063717272467\ \(0\)\
\-\ 114\\:\\ 0\\.00833063717272467\ \(0\)\
\-\ lin\\:\\ 0\\.00833063717272467\ \(0\)\
\-\ ross\\:\\ 0\\.00833063717272467\ \(0\)\
\-\ found\\:\\ 0\\.008286232659852653\ \(0\)\
\-\ despite\\:\\ 0\\.008146320692323912\ \(0\)\
\-\ \\:\\:\\ 0\\.00811479355070221\ \(0\)\
\-\ flair\\:\\ 0\\.008036263844134537\ \(0\)\
\-\ some\\:\\ 0\\.007984394627282336\ \(0\)\
\-\ diffuse\\:\\ 0\\.007960022831924046\ \(0\)\
\-\ j\\:\\ 0\\.007917315623313308\ \(0\)\
\-\ gbms\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ interpret\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ mannitol\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ shifts\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ existence\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ js\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ neurorx\\:\\ 0\\.007914775523382963\ \(0\)\
\-\ a\\:\\ 0\\.007728611522618897\ \(0\)\
\-\ fall\\:\\ 0\\.00771132844844757\ \(0\)\
\-\ confer\\:\\ 0\\.007619716987534982\ \(0\)\
\-\ compounds\\:\\ 0\\.007619716987534982\ \(0\)\
\-\ inexpensive\\:\\ 0\\.007619716987534982\ \(0\)\
\-\ dn\\:\\ 0\\.007619716987534982\ \(0\)\
\-\ chang\\:\\ 0\\.007619716987534982\ \(0\)\
\-\ do\\:\\ 0\\.007609380410391626\ \(0\)\
\-\ total\\:\\ 0\\.0075481435629051\ \(0\)\
\-\ t2\\:\\ 0\\.007441811596154929\ \(0\)\
\-\ astrocytic\\:\\ 0\\.007390851806699896\ \(0\)\
\-\ hunter\\:\\ 0\\.007390851806699896\ \(0\)\
\-\ he\\:\\ 0\\.007335961052409291\ \(0\)\
\-\ same\\:\\ 0\\.007225053536906679\ \(0\)\
\-\ understand\\:\\ 0\\.007203855338193275\ \(0\)\
\-\ ef\\:\\ 0\\.007203855338193275\ \(0\)\
\-\ bd\\:\\ 0\\.007203855338193275\ \(0\)\
\-\ composition\\:\\ 0\\.007045752076831984\ \(0\)\
\-\ correctly\\:\\ 0\\.007045752076831984\ \(0\)\
\-\ technology\\:\\ 0\\.007045752076831984\ \(0\)\
\-\ sr\\:\\ 0\\.007045752076831984\ \(0\)\
\-\ instance\\:\\ 0\\.006908796802345294\ \(0\)\
\-\ turnover\\:\\ 0\\.006908796802345294\ \(0\)\
\-\ acta\\:\\ 0\\.006908796802345294\ \(0\)\
\-\ this\\:\\ 0\\.006900472300716853\ \(0\)\
\-\ than\\:\\ 0\\.006889381092056227\ \(0\)\
\-\ similar\\:\\ 0\\.006875254602955668\ \(0\)\
\-\ suppress\\:\\ 0\\.006787993688851568\ \(0\)\
\-\ creates\\:\\ 0\\.006787993688851568\ \(0\)\
\-\ noninvasive\\:\\ 0\\.006787993688851568\ \(0\)\
\-\ oncol\\:\\ 0\\.006787993688851568\ \(0\)\
\-\ examining\\:\\ 0\\.006679931621510208\ \(0\)\
\-\ indicator\\:\\ 0\\.006679931621510208\ \(0\)\
\-\ tumours\\:\\ 0\\.006679931621510208\ \(0\)\
\-\ grade\\:\\ 0\\.00667658829323276\ \(0\)\
\-\ 50\\:\\ 0\\.006668713880294984\ \(0\)\
\-\ pxa\\:\\ 0\\.0065821775909416695\ \(0\)\
\-\ neurocysticercosis\\:\\ 0\\.0065821775909416695\ \(0\)\
\-\ neurosurgeon\\:\\ 0\\.0065821775909416695\ \(0\)\
\-\ scant\\:\\ 0\\.0065821775909416695\ \(0\)\
\-\ sulcal\\:\\ 0\\.006410840068210216\ \(0\)\
\-\ chosen\\:\\ 0\\.006410840068210216\ \(0\)\
\-\ utility\\:\\ 0\\.006410840068210216\ \(0\)\
\-\ hemispheric\\:\\ 0\\.006410840068210216\ \(0\)\
\-\ dysembryoplastic\\:\\ 0\\.006334831891642297\ \(0\)\
\-\ elected\\:\\ 0\\.0062640699721685\ \(0\)\
\-\ 2\\.9\\:\\ 0\\.0062640699721685\ \(0\)\
\-\ changing\\:\\ 0\\.0062640699721685\ \(0\)\
\-\ physicians\\:\\ 0\\.0062640699721685\ \(0\)\
\-\ closer\\:\\ 0\\.006197876617155607\ \(0\)\
\-\ typically\\:\\ 0\\.0061875400400122505\ \(0\)\
\-\ 3\\:\\ 0\\.00615684777448166\ \(0\)\
\-\ lactate\\:\\ 0\\.006135697517856699\ \(0\)\
\-\ request\\:\\ 0\\.006135697517856699\ \(0\)\
\-\ efficacy\\:\\ 0\\.006135697517856699\ \(0\)\
\-\ \\%\\:\\ 0\\.006133295487218485\ \(0\)\
\-\ location\\:\\ 0\\.006114272178264396\ \(0\)\
\-\ being\\:\\ 0\\.006108283029334478\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.006077073503661881\ \(0\)\
\-\ uses\\:\\ 0\\.006077073503661881\ \(0\)\
\-\ in\\:\\ 0\\.006050832022526737\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006037597940862831\ \(0\)\
\-\ xanthoastrocytoma\\:\\ 0\\.006021619943384675\ \(0\)\
\-\ assist\\:\\ 0\\.006021619943384675\ \(0\)\
\-\ upward\\:\\ 0\\.006021619943384675\ \(0\)\
\-\ are\\:\\ 0\\.0059737121668184704\ \(0\)\
\-\ suppression\\:\\ 0\\.00596901143632052\ \(0\)\
\-\ mechanisms\\:\\ 0\\.00596901143632052\ \(0\)\
\-\ creating\\:\\ 0\\.00596901143632052\ \(0\)\
\-\ present\\:\\ 0\\.005938488473635941\ \(0\)\
\-\ neuroepithelial\\:\\ 0\\.005918970242300589\ \(0\)\
\-\ recur\\:\\ 0\\.005918970242300589\ \(0\)\
\-\ physiologic\\:\\ 0\\.005918970242300589\ \(0\)\
\-\ louis\\:\\ 0\\.005918970242300589\ \(0\)\
\-\ turn\\:\\ 0\\.005871257405751982\ \(0\)\
\-\ pathologically\\:\\ 0\\.005825665854397281\ \(0\)\
\-\ nervous\\:\\ 0\\.005825665854397281\ \(0\)\
\-\ \\>\\:\\ 0\\.005823933363422696\ \(0\)\
\-\ x\\:\\ 0\\.005782700175071748\ \(0\)\
\-\ progressing\\:\\ 0\\.0057820149678139\ \(0\)\
\-\ conducted\\:\\ 0\\.0057820149678139\ \(0\)\
\-\ prospective\\:\\ 0\\.0057820149678139\ \(0\)\
\-\ is\\:\\ 0\\.005767084906510006\ \(0\)\
\-\ mistaken\\:\\ 0\\.005740146255485433\ \(0\)\
\-\ pre\\-op\\:\\ 0\\.005740146255485433\ \(0\)\
\-\ controversial\\:\\ 0\\.005740146255485433\ \(0\)\
\-\ decision\\:\\ 0\\.0056999198830205286\ \(0\)\
\-\ to\\:\\ 0\\.005694241445906484\ \(0\)\
\-\ 4cm\\:\\ 0\\.005661211854320174\ \(0\)\
\-\ read\\:\\ 0\\.005661211854320174\ \(0\)\
\-\ supratentorial\\:\\ 0\\.005661211854320174\ \(0\)\
\-\ certain\\:\\ 0\\.00562391170645261\ \(0\)\
\-\ often\\:\\ 0\\.005592766253373646\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.005519519199468054\ \(0\)\
\-\ instead\\:\\ 0\\.005519519199468054\ \(0\)\
\-\ trial\\:\\ 0\\.005519519199468054\ \(0\)\
\-\ frontal\\:\\ 0\\.005506239865606887\ \(0\)\
\-\ dnet\\:\\ 0\\.005486956431965919\ \(0\)\
\-\ will\\:\\ 0\\.005484063627444394\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.005424777332667012\ \(0\)\
\-\ chemical\\:\\ 0\\.005395046525617522\ \(0\)\
\-\ clinical\\:\\ 0\\.005393456000135393\ \(0\)\
\-\ takes\\:\\ 0\\.005366153318472193\ \(0\)\
\-\ preoperative\\:\\ 0\\.005366153318472193\ \(0\)\
\-\ neonatal\\:\\ 0\\.005258091251130833\ \(0\)\
\-\ eg\\:\\ 0\\.005258091251130833\ \(0\)\
\-\ already\\:\\ 0\\.005208050057110902\ \(0\)\
\-\ variety\\:\\ 0\\.005183916213613267\ \(0\)\
\-\ decade\\:\\ 0\\.005160337220562294\ \(0\)\
\-\ years\\:\\ 0\\.005147165409268682\ \(0\)\
\-\ post\\-op\\:\\ 0\\.005137288137637106\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.005114745669207593\ \(0\)\
\-\ locations\\:\\ 0\\.005114745669207593\ \(0\)\
\-\ infiltrative\\:\\ 0\\.005029226070295745\ \(0\)\
\-\ unfortunately\\:\\ 0\\.005029226070295745\ \(0\)\
\-\ scale\\:\\ 0\\.005008915683325304\ \(0\)\
\-\ creatinine\\:\\ 0\\.004988999697830842\ \(0\)\
\-\ indicate\\:\\ 0\\.004969463087604489\ \(0\)\
\-\ region\\:\\ 0\\.004950976876388334\ \(0\)\
\-\ 2007\\:\\ 0\\.004950291669130486\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.004931472039727208\ \(0\)\
\-\ according\\:\\ 0\\.004877000424020594\ \(0\)\
\-\ look\\:\\ 0\\.004877000424020594\ \(0\)\
\-\ smith\\:\\ 0\\.004877000424020594\ \(0\)\
\-\ low\\:\\ 0\\.004874190877674666\ \(0\)\
\-\ making\\:\\ 0\\.004859467671857209\ \(0\)\
\-\ an\\:\\ 0\\.004847855853475815\ \(0\)\
\-\ growing\\:\\ 0\\.004842229601789126\ \(0\)\
\-\ various\\:\\ 0\\.004842229601789126\ \(0\)\
\-\ effacement\\:\\ 0\\.004808599014278366\ \(0\)\
\-\ experience\\:\\ 0\\.004808599014278366\ \(0\)\
\-\ high\\:\\ 0\\.004797017561183212\ \(0\)\
\-\ infiltration\\:\\ 0\\.004776036246776231\ \(0\)\
\-\ been\\:\\ 0\\.004768810029669725\ \(0\)\
\-\ lobe\\:\\ 0\\.004716564816253403\ \(0\)\
\-\ whether\\:\\ 0\\.004713857147477325\ \(0\)\
\-\ survival\\:\\ 0\\.004698884019865885\ \(0\)\
\-\ make\\:\\ 0\\.004684126340427835\ \(0\)\
\-\ glucose\\:\\ 0\\.004684126340427835\ \(0\)\
\-\ variable\\:\\ 0\\.004669577996846341\ \(0\)\
\-\ improve\\:\\ 0\\.004669577996846341\ \(0\)\
\-\ pilocytic\\:\\ 0\\.004613364420954039\ \(0\)\
\-\ occasionally\\:\\ 0\\.004613364420954039\ \(0\)\
\-\ h\\:\\ 0\\.004613364420954039\ \(0\)\
\-\ continues\\:\\ 0\\.004573138048489135\ \(0\)\
\-\ late\\:\\ 0\\.004560072381025105\ \(0\)\
\-\ that\\:\\ 0\\.00454147916479638\ \(0\)\
\-\ the\\:\\ 0\\.004537412421042077\ \(0\)\
\-\ patients\\:\\ 0\\.004536563280750822\ \(0\)\
\-\ better\\:\\ 0\\.0045218453094382\ \(0\)\
\-\ nuclear\\:\\ 0\\.0045218453094382\ \(0\)\
\-\ representing\\:\\ 0\\.0045218453094382\ \(0\)\
\-\ neuro\\:\\ 0\\.0045218453094382\ \(0\)\
\-\ cns\\:\\ 0\\.004484991966642237\ \(0\)\
\-\ adults\\:\\ 0\\.004472996028423579\ \(0\)\
\-\ corresponding\\:\\ 0\\.004461138774678887\ \(0\)\
\-\ neoplasms\\:\\ 0\\.004461138774678887\ \(0\)\
\-\ degrees\\:\\ 0\\.0044494170353726065\ \(0\)\
\-\ determine\\:\\ 0\\.004437827747932676\ \(0\)\
\-\ neural\\:\\ 0\\.004437827747932676\ \(0\)\
\-\ anatomic\\:\\ 0\\.004426367952447419\ \(0\)\
\-\ alcohol\\:\\ 0\\.004415034787127845\ \(0\)\
\-\ no\\:\\ 0\\.004412534106173344\ \(0\)\
\-\ patient\\:\\ 0\\.004392779132904554\ \(0\)\
\-\ adult\\:\\ 0\\.004392737364936659\ \(0\)\
\-\ more\\:\\ 0\\.004383951403717264\ \(0\)\
\-\ bright\\:\\ 0\\.00438176783763743\ \(0\)\
\-\ conditions\\:\\ 0\\.004360174597434525\ \(0\)\
\-\ enhance\\:\\ 0\\.0042393714839407985\ \(0\)\
\-\ shift\\:\\ 0\\.0041572763991474275\ \(0\)\
\-\ tissue\\:\\ 0\\.004154710130159166\ \(0\)\
\-\ 90\\:\\ 0\\.004131309416599439\ \(0\)\
\-\ b\\:\\ 0\\.004131309416599439\ \(0\)\
\-\ 80\\:\\ 0\\.004122797823968982\ \(0\)\
\-\ states\\:\\ 0\\.004122797823968982\ \(0\)\
\-\ normal\\:\\ 0\\.004121884475689542\ \(0\)\
\-\ degree\\:\\ 0\\.004105983660096493\ \(0\)\
\-\ major\\:\\ 0\\.004097678829088678\ \(0\)\
\-\ 45\\:\\ 0\\.004049214331806068\ \(0\)\
\-\ other\\:\\ 0\\.004040284202466562\ \(0\)\
\-\ 35\\:\\ 0\\.004033555386030899\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.004025814662302302\ \(0\)\
\-\ incidence\\:\\ 0\\.004018131922067268\ \(0\)\
\-\ decrease\\:\\ 0\\.004010506303105711\ \(0\)\
\-\ glioma\\:\\ 0\\.003951460301237529\ \(0\)\
\-\ generally\\:\\ 0\\.003944312948092818\ \(0\)\
\-\ of\\:\\ 0\\.003943205565470377\ \(0\)\
\-\ medications\\:\\ 0\\.003909304736431835\ \(0\)\
\-\ represent\\:\\ 0\\.0038491521958354167\ \(0\)\
\-\ difficult\\:\\ 0\\.0038362508807514577\ \(0\)\
\-\ their\\:\\ 0\\.0038362508807514577\ \(0\)\
\-\ pathologic\\:\\ 0\\.0038362508807514577\ \(0\)\
\-\ life\\:\\ 0\\.0038235098345990913\ \(0\)\
\-\ recurrence\\:\\ 0\\.0038235098345990913\ \(0\)\
\-\ needed\\:\\ 0\\.003817198177599729\ \(0\)\
\-\ not\\:\\ 0\\.0037994420668982626\ \(0\)\
\-\ additionally\\:\\ 0\\.003798492959599954\ \(0\)\
\-\ neurological\\:\\ 0\\.0037923329349228135\ \(0\)\
\-\ 5\\.\\:\\ 0\\.003780122778506077\ \(0\)\
\-\ relatively\\:\\ 0\\.0037502185894891992\ \(0\)\
\-\ for\\:\\ 0\\.0037390161468857184\ \(0\)\
\-\ function\\:\\ 0\\.003715447767257731\ \(0\)\
\-\ compared\\:\\ 0\\.003709765530975049\ \(0\)\
\-\ 40\\:\\ 0\\.0036873462552699213\ \(0\)\
\-\ increase\\:\\ 0\\.0036763177508840118\ \(0\)\
\-\ history\\:\\ 0\\.003631429346791026\ \(0\)\
\-\ after\\:\\ 0\\.0036266691335573383\ \(0\)\
\-\ 9\\:\\ 0\\.003622886866901036\ \(0\)\
\-\ free\\:\\ 0\\.003607385699916371\ \(0\)\
\-\ many\\:\\ 0\\.0036022702727255616\ \(0\)\
\-\ tissues\\:\\ 0\\.0035971802323746596\ \(0\)\
\-\ pathology\\:\\ 0\\.00358707531294593\ \(0\)\
\-\ results\\:\\ 0\\.0035379922143022016\ \(0\)\
\-\ attenuation\\:\\ 0\\.003523713918385681\ \(0\)\
\-\ complex\\:\\ 0\\.0035096316693478324\ \(0\)\
\-\ and\\:\\ 0\\.003507867804012462\ \(0\)\
\-\ measuring\\:\\ 0\\.0035049802281525593\ \(0\)\
\-\ also\\:\\ 0\\.0034556299357336438\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0034507486875905618\ \(0\)\
\-\ midline\\:\\ 0\\.003390902653680534\ \(0\)\
\-\ used\\:\\ 0\\.0033622401609722683\ \(0\)\
\-\ incidental\\:\\ 0\\.0033187575363900264\ \(0\)\
\-\ course\\:\\ 0\\.0033072117368775807\ \(0\)\
\-\ tumors\\:\\ 0\\.00329201677709795\ \(0\)\
\-\ greater\\:\\ 0\\.00329201677709795\ \(0\)\
\-\ metastasis\\:\\ 0\\.003280766488512745\ \(0\)\
\-\ abnormality\\:\\ 0\\.0032333927629031303\ \(0\)\
\-\ breast\\:\\ 0\\.0032333927629031303\ \(0\)\
\-\ intensity\\:\\ 0\\.0031678673603890268\ \(0\)\
\-\ malignant\\:\\ 0\\.0031678673603890268\ \(0\)\
\-\ including\\:\\ 0\\.0031645319394799218\ \(0\)\
\-\ they\\:\\ 0\\.003157893463063904\ \(0\)\
\-\ 20\\:\\ 0\\.0031512976781097597\ \(0\)\
\-\ kidney\\:\\ 0\\.003087572774410266\ \(0\)\
\-\ benign\\:\\ 0\\.0030246670431109757\ \(0\)\
\-\ liver\\:\\ 0\\.003021765652136127\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0029988453457853613\ \(0\)\
\-\ elevated\\:\\ 0\\.002973657806522116\ \(0\)\
\-\ masses\\:\\ 0\\.0029626588697395768\ \(0\)\
\-\ 10\\:\\ 0\\.0029544863880481133\ \(0\)\
\-\ size\\:\\ 0\\.00293833422705515\ \(0\)\
\-\ cases\\:\\ 0\\.002919806014339623\ \(0\)\
\-\ by\\:\\ 0\\.0029187095451176917\ \(0\)\
\-\ central\\:\\ 0\\.002883724468574317\ \(0\)\
\-\ surrounding\\:\\ 0\\.0028811951429382207\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0027871221967182137\ \(0\)\
\-\ t1\\:\\ 0\\.0027779441397171732\ \(0\)\
\-\ known\\:\\ 0\\.0027733857276551997\ \(0\)\
\-\ any\\:\\ 0\\.0027598308031510704\ \(0\)\
\-\ while\\:\\ 0\\.002757588963951091\ \(0\)\
\-\ aspect\\:\\ 0\\.0027531199328034435\ \(0\)\
\-\ image\\:\\ 0\\.0027376299141513853\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0027376299141513853\ \(0\)\
\-\ age\\:\\ 0\\.0026676003338915962\ \(0\)\
\-\ month\\:\\ 0\\.002629348246974984\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0026195146047645703\ \(0\)\
\-\ see\\:\\ 0\\.0026156073961320905\ \(0\)\
\-\ there\\:\\ 0\\.002608647295312797\ \(0\)\
\-\ s\\:\\ 0\\.0025136078637072686\ \(0\)\
\-\ when\\:\\ 0\\.002510083320631801\ \(0\)\
\-\ appearance\\:\\ 0\\.0025065708479329657\ \(0\)\
\-\ following\\:\\ 0\\.00248746436605246\ \(0\)\
\-\ head\\:\\ 0\\.002485744933921945\ \(0\)\
\-\ edema\\:\\ 0\\.002478895886596196\ \(0\)\
\-\ all\\:\\ 0\\.002478895886596196\ \(0\)\
\-\ time\\:\\ 0\\.002475488438194167\ \(0\)\
\-\ include\\:\\ 0\\.0024586189620823453\ \(0\)\
\-\ ct\\:\\ 0\\.00245190493003496\ \(0\)\
\-\ 4\\:\\ 0\\.0024420224668503026\ \(0\)\
\-\ mass\\:\\ 0\\.0024378687322001323\ \(0\)\
\-\ if\\:\\ 0\\.0023781983936211645\ \(0\)\
\-\ one\\:\\ 0\\.00237510911108784\ \(0\)\
\-\ at\\:\\ 0\\.002374898775039247\ \(0\)\
\-\ cm\\:\\ 0\\.0023507242234020367\ \(0\)\
\-\ enhancement\\:\\ 0\\.0023492192473056777\ \(0\)\
\-\ due\\:\\ 0\\.0023387457979003484\ \(0\)\
\-\ signal\\:\\ 0\\.0023108454669464396\ \(0\)\
\-\ common\\:\\ 0\\.002293607396878356\ \(0\)\
\-\ over\\:\\ 0\\.0022314282975794486\ \(0\)\
\-\ increased\\:\\ 0\\.0021440869556919547\ \(0\)\
\-\ 1\\:\\ 0\\.002085462941497135\ \(0\)\
\-\ into\\:\\ 0\\.002085462941497135\ \(0\)\
\-\ man\\:\\ 0\\.002072750608297435\ \(0\)\
\-\ without\\:\\ 0\\.002063603247546831\ \(0\)\
\-\ imaging\\:\\ 0\\.002053409050723695\ \(0\)\
\-\ tumor\\:\\ 0\\.0020433151811392936\ \(0\)\
\-\ \\.\\:\\ 0\\.0020389477143091194\ \(0\)\
\-\ most\\:\\ 0\\.0020234206581826422\ \(0\)\
\-\ small\\:\\ 0\\.0020190515737242244\ \(0\)\
\-\ year\\:\\ 0\\.0019612415779957223\ \(0\)\
\-\ may\\:\\ 0\\.0019223880706647424\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0019144832837468574\ \(0\)\
\-\ had\\:\\ 0\\.0018911280197340598\ \(0\)\
\-\ \\-\\:\\ 0\\.001878695855085501\ \(0\)\
\-\ right\\:\\ 0\\.0018495009417649573\ \(0\)\
\-\ presents\\:\\ 0\\.0017904044056491547\ \(0\)\
\-\ treatment\\:\\ 0\\.0017739661124111662\ \(0\)\
\-\ seen\\:\\ 0\\.001731925759043785\ \(0\)\
\-\ which\\:\\ 0\\.001636045730505178\ \(0\)\
\-\ as\\:\\ 0\\.001325720518865772\ \(0\)\
\-\ left\\:\\ 0\\.0009806207889978612\ \(0\)\
\-\ old\\:\\ 0\\.0008973688172946201\ \(0\)\
\-\ with\\:\\ 0\\.00048001713267647073\ \(0\)\
